Drugs / Paxerol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02646826 | Jan 2016 → Oct 2017 | nocturnal enuresis | Wellesley Pharmaceuticals, LLC | Completed | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Paxerol | “Paxerol™ (a Novel Formulation of Acetaminophen and Ibuprofen) for Treatment of Nocturia - A Phase II Placebo-Controlled Trial” NCT02646826 ↗ |
| Route | Oral | “daily oral administration” NCT02646826 ↗ |